GE HealthCare Technologies Inc

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

GE HealthCare posts robust Q4 results, eyes growth opportunities

GE HealthCare Technologies Inc delivered a strong Q4 2022 performance with notable organic revenue growth and margin expansion.
While facing challenges such as COVID-related impacts and debt interest, the company is well-positioned for growth through pricing strategies and market demand.
Opportunities lie in continued revenue growth, margin expansion, and product innovations, supported by strong market demand and strategic initiatives.
Overall, GE HealthCare's focus on performance improvement, innovation, and financial discipline sets a positive trajectory for future growth and competitiveness.

GE HealthCare reports robust Q1 earnings, eyes growth opportunities

GE HealthCare Technologies Inc delivered strong financial results in Q1 2023, with revenue growth, margin improvement, and reaffirmed guidance for the full year. The company's focus on innovation, technology investments, and strategic acquisitions positions it well for future growth.

GE HealthCare reports strong Q2 earnings, eyes precision care growth

GE HealthCare Technologies delivered strong financial performance in Q2 2023, driven by revenue growth, innovation in AI technologies, and strategic investments in key segments.
While facing challenges such as margin improvements and geopolitical risks, the company remains focused on capitalizing on growth opportunities in precision care and technological advancements.
Executives emphasized a balanced approach to capital allocation, margin expansion, and long-term growth strategies, positioning GEHC for sustained success in the evolving healthcare landscape.
Overall, GEHC's Q2 earnings call highlighted a resilient business outlook, with a clear focus on driving innovation, enhancing margins, and seizing opportunities for growth and market leadership.

GE HealthCare reports solid Q3 growth, eyes opportunities amid challenges

GE HealthCare Technologies Inc reported strong Q3 2023 performance with revenue growth, margin expansion, and strategic collaborations.
The company faces challenges in capital spending sentiment, margin targets, and managing balance sheet risks.
Opportunities for growth include new product launches, market focus, and upcoming investor engagements.
Overall, GEHC's resilience, operational improvements, and growth strategies position it well for future success.

GE HealthCare reports robust earnings, eyes growth through innovation

GE HealthCare Technologies Inc delivered strong financial performance in Q4 2023 and full-year 2023, driven by organic growth, strategic acquisitions, and margin expansion initiatives.
While facing challenges such as anticipated market declines and macroeconomic uncertainties, the company is well-positioned to leverage opportunities in increased demand, innovative technologies, and strategic partnerships.
By focusing on driving value through innovation, sustainability, and strategic investments, GE HealthCare is poised for continued growth and market leadership in the healthcare technology sector.
The outlook for 2024 indicates a positive trajectory with anticipated revenue growth, margin expansion, and a commitment to delivering high-value solutions to customers, supported by a strong financial foundation.

GE Healthcare reports steady Q1 performance amidst global challenges

GE Healthcare Technologies showcased a mixed performance in Q1 2024, with flat organic revenue growth and varied segment results.
The company remains focused on strategic alliances, margin initiatives, and cost savings to support EBIT expansion and solid margin performance.
Challenges in China sales and the need for clarity on the stimulus package present uncertainties, while opportunities lie in segment growth and new product introductions.

GE HealthCare reports steady Q2 growth amidst China challenges

GE HealthCare Technologies Inc delivered solid Q2 performance with growth in key segments like Patient Care Solutions and Pharmaceutical Diagnostics. Despite challenges in China, the company remains focused on driving margin expansion and innovation for sustained growth.

GE HealthCare reports steady Q3 growth amidst China market challenges

GE HealthCare Technologies Inc delivered a solid financial performance in Q3 2024, with 1% organic revenue growth and strong margin performance.
While facing challenges in the slow recovery of the China market, the company showcased strengths in free cash flow generation and technological innovations.
Future opportunities lie in margin expansion, growth initiatives like Flyrcado and AI solutions, and market differentiation through innovative healthcare technologies.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.

Is this red-hot healthcare stock still a buy?

GE Healthcare Stock: Bull vs. Bear

General Electric

The newly listed healthcare company gave its first set of earnings as a stand-alone company, and while there were some negatives, its future looks bright.

How GE HealthCare Technologies Is Shaping Up for 2023

The newly listed company pleased investors with its presentations throughout the month.

Why Shares in GE HealthCare Technologies Soared in January

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q4 2022 Earnings Conference Call January 30, 2023 8:00 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Helmut Zodl - Vice President and Chief Financial Officer Conference Call Participants Drew Ranieri - Morgan Stanley Ed Ridley-Day - Redburn Vijay Kumar - Evercore Lawrence Biegelsen - Wells Fargo Veronika Dubajova - Citigroup Anthony Petrone - Mizuho Ryan Zimmerman - BTIG Jason Bednar - Piper Sandler Yuan Zhi - B. Riley Operator Good day, ladies and gentlemen, and welcome to the GE HealthCare Fourth Quarter 2022 Earnings Conference Call.

GE HealthCare Technologies Inc. (GEHC) Q4 2022 Earnings Call Transcript

General Electric (NYSE: GE) completed the spinoff of GE Healthcare Technologies, Inc (NASDAQ: GEHC) in December 2022, and the first earrings report is in. The news affirms the company's decision to split into 3 companies as it is a path to unlocking shareholder value.

GE Healthcare Technology: Speculating On Dividends

The company was spun out of General Electric on Jan 3. It posted fourth-quarter earnings per share of $1.31 and sales of just more than $4.9 billion.

GE HealthCare's First Solo Earnings Were Strong

The company was spun out of General Electric on Jan 3. It posted fourth-quarter earnings per share of $1.31 and operating income of $844 million from sales of just more than $4.9 billion.

GE HealthCare's First Solo Earnings Are Strong. It's Bullish on the Future.

Shares of GE HealthCare GEHC, slipped 0.1% in premarket trading Monday, after the medical technology and pharmaceutical diagnostics company reported its first results as a public company, with fourth-quarter profit falling from a year ago while revenue rose. The company, which completed its spinoff from General Electric Co. GE, +2.58% on Jan. 3, said net income slipped 1.8% to $554 million, as earning per share from continuing operations fell to $1.21 from $1.24.

GE HealthCare reports first results after GE spinoff, with revenue rising 8% but profit slipping

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the fourth quarter and full year ended December 31, 2022.

GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results

This healthcare giant has plenty of earnings growth potential and trades at an attractive valuation.

Buy This Exceptional Stock Before Wall Street Finds Out

Alliance Resource Partners

Li-Cycle Holdings Corp

SoFi Technologies

In early trading Thursday, the Dow Jones industrials were up 0.35%, the S&P 500 was up 0.65% and the Nasdaq was up 1.16%.

Earnings Previews: Alliance Resource Partners, GE Healthcare, Li-Cycle, SoFi Technologies

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC) and Sound Technologies, the global veterinary imaging leader, today announced an agreement to distribute the Vscan Air™, a cutting-edge, wireless pocket-sized ultrasound that provides crystal clear image quality, whole-patient scanning capabilities, and intuitive software – to veterinary practices in the United States.

Sound Technologies and GE HealthCare Announce Collaboration to Bring Vscan Air Handheld Ultrasound to Veterinary Practices Across the United States

Investors could be better off if GE HealthCare uses its cash for other purposes.

Will GE HealthCare Stock Pay a Dividend Anytime Soon?

Cost-saving multi-year agreement to provide innovative technology, help improve patient outcomes, and enhance staff wellbeing Cost-saving multi-year agreement to provide innovative technology, help improve patient outcomes, and enhance staff wellbeing

GE HealthCare and Windsor Regional Hospital Enter Long-Term Innovative Technology Agreement

Apple

An undervalued spinoff, a company continuing to transform its margin potential, and a technology giant growing its services revenue make up a list of stocks smart investors are looking at.

Dow Jones Bear Market: The Smartest Investors Are Buying These Beaten Down Stocks

D.R. Horton

Halliburton

Lockheed Martin

Raytheon Technologies

Shortly after Friday's opening bell, the Dow Jones industrial average traded down 0.15%, while the S&P 500 traded up 0.25% and the Nasdaq Composite was up 0.77%.

Earnings Preview: DR Horton, General Electric, Halliburton, Lockheed Martin, Raytheon

Amazon

Equinix

Palo Alto Networks

Last year was terrible for some of the best cloud computing stocks, and for the Cloud Czars whose cash flow built it. Apple (NASDAQ: AAPL ), Microsoft (NASDAQ: MSFT ), Alphabet (NASDAQ: GOOGL , GOOG ), Amazon.Com (NASDAQ: AMZN ), and Meta Platforms (NASDAQ: META ) combined to lose trillions of dollars in market cap.

The 5 Best Cloud Computing Stocks to Buy for 2023

The newly minted stock has its positives and negatives.

Is GE HealthCare Stock a Screaming Buy After Its Spinoff?

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its fourth quarter and full year 2022 financial results before the market opens on Monday, January 30, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:00 a.m. Eastern Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay will also all be posted at the same link on the GE HealthCare Investor Relations website.

GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023

Is the new healthcare stock a buy for 2023?

Own GE HealthCare Stock? Here's What You Need to Know About the Spin-Off

GE HealthCare Technologies' shares rose on Wednesday after the company issued preliminary results for the fourth quarter and forecast continued organic revenue growth in the year ahead. The company, which completed its spin-off from General Electric (NYSE:GE) last week, said it expects 2023 organic revenue to grow by 5% to 7% from 2022 levels.

GE HealthCare Technologies jumps 8% as it forecasts continued revenue growth in 2023

The market liked what it heard from the GE spinoff's preliminary results release.

Why GE HealthCare Technologies Surged Higher Today

Ge Healthcare Technologies Inc. GEHC, -1.44% , the unit recently spun out of General Electric Co. GE, +1.01% , said Tuesday it expects fourth-quarter revenue to come to about $4.9 billion and for full-year revenue to total $18.3 billion. There are currently no FactSet consensus numbers for the new public company.

GE Healthcare sees Q4 revenue of about $4.9 billion

CHICAGO--( BUSINESS WIRE )--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full year 2022. The Company also issued Organic revenue growth*, Adjusted EBIT margin*, and Free cash flow conversion* guidance for 2023. President and Chief Executive Officer Peter Arduini and Chief Financial Officer Helmut Zodl will comment on these results at the 41st Annual J.P. Morgan Healthcare Conference today in San Francisco.

GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

GE HealthCare Technologies Inc. GEHC, -1.44% late Monday said it has agreed to buy French tomography company IMACTIS for an undisclosed amount. IMACTIS's system is designed to increase the procedure's accuracy while helping reduce procedure time and radiation doses for patients and doctors, GE HealthCare said.

News for GE HealthCare Technologies Inc Stock (GEHC)